Palomino Laboratories (PALX) Accounts Payables (2022 - 2025)
Palomino Laboratories (PALX) posted Accounts Payables of $55687.0 for Q4 2025, down 8.64% sequentially from $60952.0 in Q3 2025, and up 1592.1% YoY from $3291.0 in Q4 2024.
Palomino Laboratories (PALX) Accounts Payables (2022 - 2025) Analysis & Trends
Palomino Laboratories has reported Accounts Payables for 4 years, with the latest figure at $55687.0 in Q4 2025.
- Quarterly Accounts Payables rose 1592.1% year-over-year to $55687.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $55687.0 (up 1592.1% YoY) and the FY2025 annual result came in at $55687.0, up 1592.1% from the prior year.
- Accounts Payables declined to $55687.0 in Q4 2025 per PALX's latest filing, from $60952.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $60952.0 in Q3 2025 and troughed at $58.0 in Q4 2023.
- A 4-year average of $35037.1 and a median of $43954.0 in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables plunged 99.54% in 2023, then soared 5574.14% in 2024.
- Over 4 years, Accounts Payables stood at $12500.0 in 2022, then slumped by 99.54% to $58.0 in 2023, then jumped by 5574.14% to $3291.0 in 2024, then jumped by 1592.1% to $55687.0 in 2025.
- According to Business Quant data, Accounts Payables over the past three periods registered $55687.0, $60952.0, and $40781.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,687.00 |
| Sep 30, 2025 | 60,952.00 |
| Jun 30, 2025 | 40,781.00 |
| Mar 31, 2025 | 45,816.00 |
| Dec 31, 2024 | 3,291.00 |
| Sep 30, 2024 | 46,757.00 |
| Jun 30, 2024 | 43,954.00 |
| Mar 31, 2024 | 47,112.00 |
| Dec 31, 2023 | 58.00 |
| Sep 30, 2023 | 28,500.00 |
| Dec 31, 2022 | 12,500.00 |